Suppression of β Cell Energy Metabolism and Insulin Release by PGC-1α

J.Cliff Yoon,Gang Xu,Jude T Deeney,Shao-Nian Yang,James Rhee,Pere Puigserver,Adah R Levens,Ruojing Yang,Chen-Yu Zhang,Bradford B Lowell,Per-Olof Berggren,Christopher B Newgard,Susan Bonner-Weir,Gordon Weir,Bruce M Spiegelman
DOI: https://doi.org/10.1016/S1534-5807(03)00170-9
IF: 13.417
2003-01-01
Developmental Cell
Abstract:β cell dysfunction is an important component of type 2 diabetes, but the molecular basis for this defect is poorly understood. The transcriptional coactivator PGC-1α mRNA and protein levels are significantly elevated in islets from multiple animal models of diabetes; adenovirus-mediated expression of PGC-1α to levels similar to those present in diabetic rodents produces a marked inhibition of glucose-stimulated insulin secretion from islets in culture and in live mice. This inhibition coincides with changes in metabolic gene expression associated with impaired β cell function, including the induction of glucose-6-phosphatase and suppression of GLUT2, glucokinase, and glycerol-3-phosphate dehydrogenase. These changes result in blunting of the glucose-induced rise in cellular ATP levels and membrane electrical activity responsible for Ca2+ influx and insulin exocytosis. These results strongly suggest that PGC-1α plays a key functional role in the β cell and is involved in the pathogenesis of the diabetic phenotype.
What problem does this paper attempt to address?